Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Reexamination Certificate
2005-12-06
2005-12-06
Brumback, Brenda (Department: 1646)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
C435S325000, C435S252300, C435S254110, C435S254200, C435S320100, C536S023500
Reexamination Certificate
active
06972187
ABSTRACT:
The invention provides isolated nucleic acids molecules, designated OAT5 nucleic acid molecules, which encode organic anion transporters. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing OAT5 nucleic acid molecules, host cells into which the expression vectors have been introduced, and non-human transgenic animals in which a OAT5 gene has been introduced or disrupted. The invention still further provides isolated OAT5 polypeptides, fusion polypeptides, antigenic peptides and anti-OAT5 antibodies. Diagnostic and therapeutic methods utilizing compositions of the invention are also provided.
REFERENCES:
patent: 6680379 (2004-01-01), Sun
patent: WO 98/45437 (1998-10-01), None
Sweet et al., The organic anion transporter family: from physiology to ontogeny and the clinic. Am. J. Physiol. Renal Physiol. 281: F197-F205, 2001.
Fu-zhang, W., Cloning and characterization of two novel OATP genes on human 5q21.1. GenBank Database, Accession No. AY273896, Dec. 1, 2003.
DGene Accession No. AAV87708; New polynucleotides encoding human secreted proteins—derived from e.g. human blood, kidney, foetal lung, placenta, testes, brain, ovary, pituitary, retina and colon cDNA libraries (Feb. 12, 1999).
EST database Accession No. AA619778; SW:PGT_RAT Q00910 Prostaglandin Transporter (Oct. 9, 1997).
MØller, J. V. et al. “Renal Organic Anion Transport System: Pharmacological, Physiological, and Biochemical Aspects”Pharmacological ReviewsDec., 1982 vol. 34, No. 4 pp. 315-358.
Petzinger, E. “Transport of Organic Anions in the Liver. An Update on Bile Acid, Fatty Acid, Monocarboxylate, Anionic Amino Acid, Cholephilic Organic Anion, and Anionic Drug Transport”Review of Physiology, Biochemistry and Pharmacology(1994) vol. 123, pp. 47-211.
Pritchard, J.B. et al. “Mechanisms Mediating Renal Secretion of Organic Anions and Cations”Physiological ReviewsOct. 1993, vol. 73, No. 4 pp. 765-796.
Ullrich, K.J. “Renal Transporters for Organic Anions and Organic Cations, Structural Requirements for Substrates”The Journal of Membrane BiologyJul. 15, 1997, vol. 158, pp. 95-107.
Ullrich K.J. et al. “Renal Transport Mechanisms for Xenobiotics: Chemicals and Drugs”The Clinical InvestigatorOct. 1993, vol. 71, pp. 843-848.
Curtis Rory A. J.
Glucksmann Maria Alexandra
Meyers Rachel E.
Brumback Brenda
Li Ruixiang
Millennium Pharmaceuticals Inc.
Millennium Pharmaceuticals Inc.
LandOfFree
OAT5 molecules and uses therefor does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with OAT5 molecules and uses therefor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and OAT5 molecules and uses therefor will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3498358